ICVBM Home

	The Indiana Center for Vascular Biology and Medicine (ICVBM) is committed to being a leader in research in understanding mechanisms of vascular wellness and disease, and the acceleration of the development of leading-edge medical therapies to improve the care of patients with vascular problems. Directed by Keith March, M.D., Ph.D., the ICVBM includes more than 30 investigators from a range of basic as well as clinical disciplines, and is thus well-positioned to approach vascular research and development from a high cross-disciplinary perspective. This faculty, as well as the staff and students, will work together as a team to complete the primary mission of rapid development and extension to clinical application of new interdisciplinary research in vascular biology, with a key emphasis placed upon reaching patients as quickly as possible by the application of the ongoing developments of gene, molecule, and cell-based therapies.	Indiana University School of Medicine Indianapolis, Indiana To Get Directions to the ICVBM Click Here...

	Event - IFATS 2007 IFATS 2007 will be hosted in Indianapolis by the ICVBM. For more information, you can the view the IFATS site at http://www.ifats.org/
	News - April 5, 2007 Dr. Michael Murphy named finalist for the IBJ Healthcare Hero Award Dr. Michael Murphy was honored by the Indianapolis Business Journal at the Heathcare Heroes Breakfast as a finalist in the Advancement in Health Care category. Murphy was chosen for his role as the only physician in the country conducting an FDA approved Phase I clinical trial using stem cell injections to treat patients with peripheral vascular disease. Read more here...	ICVBM in the News Stem Cell Therapy for Peripheral Artery Disease (stemcellpatents.com - September 7, 2007) Adult stem cell trial sees success at IU (links to video file) (WTHR Indianapolis - February 19, 2007) Research paper by Gangaraju Rajshekhar in the Clauss Laboratory published (Journal of Vascular Research) Ind. Institute to Study Heart Disease (IndyStar.com - March 21, 2006) More News...
	Clinical Trial The “Stem Cell Mediated Angiogenesis Study” is an FDA and IRB approved Phase I clinical trial to examine how safe and effective adult stem cells are for stimulating the development of new vessels in the legs of patients with severe peripheral vascular disease. More Information... PAD Self Questionnaire (.doc file) "Adult stem cell trial sees success at IU"	Training Grant A new institutional National Institutes of Health training grant titled “Training in Vascular Biology and Medicine” is now recruiting for postdoctoral fellows to train at the Indiana University School of Medicine. More Information...

Indiana University School of Medicine Indianapolis, Indiana

Indiana University School of Medicine
Indianapolis, Indiana